Risk factors for end stage renal disease in non-wt1-syndromic wilms tumor

Journal of Urology

Volumn 186, Issue 2, 2011, Pages 378-386

  Lange, Jane ^a   Peterson, Susan M ^b   Takashima, Janice R ^b   Grigoriev, Yevgeny ^b   Ritchey, Michael L ^c   Shamberger, Robert C ^d   Beckwith, J Bruce ^e   Perlman, Elizabeth ^f   Green, Daniel M ^g   Breslow, Norman E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MAYO CLINIC   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

chronic; genes; kidney failure; nephrectomy; Wilms tumor

Indexed keywords

WT1 PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CRYPTORCHISM; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC ASSOCIATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOSPADIAS; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

CHILD, PRESCHOOL; GENES, WILMS TUMOR; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; RISK FACTORS; WILMS TUMOR;

EID: 79960187131     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.110     Document Type: Article

References (37)

1. C.A. Stiller, and D.M. Parkin International variations in the incidence of childhood renal tumours Br J Cancer 62 1990 1026
2. N.E. Breslow, A.J. Collins, and M.L. Ritchey End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System J Urol 174 2005 1972
3. L. Diller, M. Ghahremani, and J. Morgan Constitutional WT1 mutations in Wilms' tumor patients J Clin Oncol 16 1998 3634
4. R.H. Scott, C.A. Stiller, and L. Walker Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour J Med Genet 43 2006 705
5. J.B. Beckwith, C.E. Zuppan, and N.G. Browning Histological analysis of aggressiveness and responsiveness in Wilms' tumor Med Pediatr Oncol 27 1996 422
6. J.B. Beckwith, N.B. Kiviat, and J.F. Bonadio Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor Pediatr Pathol 10 1990 1
7. J.B. Beckwith Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations Am J Med Genet 79 1998 268
8. B. Royer-Pokora, M. Beier, and M. Henzler Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development Am J Med Genet A 127A 2004 249
9. N.E. Breslow, J.B. Beckwith, and E.J. Perlman Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor Pediatr Blood Cancer 47 2006 260
10. V. Schumacher, K. Scharer, and E. Wuhl Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations Kidney Int 53 1998 1594
11. J.S. Dome, E.J. Perlman, and M.L. Ritchey Renal tumors P.A. Pizzo, D.G. Poplack, Principles and Practice of Pediatric Oncology 2005 Lippincott, Williams & Wilkins Philadelphia 905 932 chapt 30
12. T.A. Gooley, W. Leisenring, and J. Crowley Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stat Med 18 1999 695
13. J.M. Satagopan, L. Ben-Porat, and M. Berwick A note on competing risks in survival data analysis Br J Cancer 91 2004 1229
14. R Development Core Team R: A Language and Environment for Statistical Computing 2010 R Foundation for Statistical Computing Vienna
15. T.E. Hamilton, M.L. Ritchey, and P. Argani Synchronous bilateral Wilm's tumor with complete radiographic response managed without surgical resection: a report from the National Wilm's Tumor Study 4 J Pediatr Surg 43 2008 1982
16. C. Song, J.K. Bang, and H.K. Park Factors influencing renal function reduction after partial nephrectomy J Urol 181 2009 48
17. M.N. Simmons, R. Brandina, and A.V. Hernandez Surgical management of bilateral synchronous kidney tumors: functional and oncological outcomes J Urol 184 2010 865
18. V. Menon, X. Wang, and M.J. Sarnak Long-term outcomes in nondiabetic chronic kidney disease Kidney Int 73 2008 1310
19. K. Pritchard-Jones Molecular genetic pathways to Wilms tumor Crit Rev Oncog 8 1997 1
20. V. Huff Wilms tumor genetics Am J Med Genet 79 1998 260
21. S.E. Little, S.P. Hanks, and L. King-Underwood Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study J Clin Oncol 22 2004 4140
22. P. Niaudet, and M.C. Gubler WT1 and glomerular diseases Pediatr Nephrol 21 2006 1653
23. B. Mucha, F. Ozaltin, and B.G. Hinkes Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9 Pediatr Res 59 2006 325
24. C. Jeanpierre, E. Denamur, and I. Henry Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database Am J Hum Genet 62 1998 824
25. B. Klamt, A. Koziell, and F. Poulat Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms Hum Mol Genet 7 1998 709
26. A.L. Menke, and A. Schedl WT1 and glomerular function Semin Cell Dev Biol 14 2003 233
27. J.K. Guo, A.L. Menke, and M.C. Gubler WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis Hum Mol Genet 11 2002 651
28. K. Dahan, M. Kamal, and L.H. Noel Small glomeruli in WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies and Mental Retardation) syndrome Am J Kidney Dis 49 2007 793
29. D. Macconi, M. Bonomelli, and A. Benigni Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury Am J Pathol 168 2006 42
30. W.E. Hoy, M.D. Hughson, and J.F. Bertram Nephron number, hypertension, renal disease, and renal failure J Am Soc Nephrol 16 2005 2557
31. A.L. Menke, A. IJpenberg, and S. Fleming The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis J Pathol 200 2003 667
32. A.M. Davidoff, D.W. Giel, and D.P. Jones The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor The St Jude Children's Research Hospital experience: 19992006 Cancer 112 2008 2060
33. J.R. Horwitz, M.L. Ritchey, and J. Moksness Renal salvage procedures in patients with synchronous bilateral Wilms' tumors: a report from the National Wilms' Tumor Study Group J Pediatr Surg 31 1996 1020
34. A. Zani, A. Schiavetti, and M. Gambino Long-term outcome of nephron sparing surgery and simple nephrectomy for unilateral localized Wilms tumor J Urol 173 2005 946
35. K. Linni, C. Urban, and H. Lackner Nephron-sparing procedures in 11 patients with Wilms' tumor Pediatr Surg Int 19 2003 457
36. F.M. Haecker, D. von Schweinitz, and D. Harms Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH J Urol 170 2003 939
37. R.C. Shamberger, K.A. Guthrie, and M.L. Ritchey Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4 Ann Surg 229 1998 292